1. Home
  2. RDY vs EVR Comparison

RDY vs EVR Comparison

Compare RDY & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • EVR
  • Stock Information
  • Founded
  • RDY 1984
  • EVR 1995
  • Country
  • RDY India
  • EVR United States
  • Employees
  • RDY N/A
  • EVR N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • EVR Investment Managers
  • Sector
  • RDY Health Care
  • EVR Finance
  • Exchange
  • RDY Nasdaq
  • EVR Nasdaq
  • Market Cap
  • RDY 11.6B
  • EVR 11.7B
  • IPO Year
  • RDY N/A
  • EVR 2006
  • Fundamental
  • Price
  • RDY $13.43
  • EVR $305.27
  • Analyst Decision
  • RDY Strong Buy
  • EVR Buy
  • Analyst Count
  • RDY 2
  • EVR 9
  • Target Price
  • RDY $16.95
  • EVR $320.11
  • AVG Volume (30 Days)
  • RDY 1.2M
  • EVR 445.8K
  • Earning Date
  • RDY 10-24-2025
  • EVR 10-29-2025
  • Dividend Yield
  • RDY 0.53%
  • EVR 1.10%
  • EPS Growth
  • RDY 9.95
  • EVR 61.35
  • EPS
  • RDY 0.79
  • EVR 12.55
  • Revenue
  • RDY $3,851,623,984.00
  • EVR $3,542,875,000.00
  • Revenue This Year
  • RDY $6.29
  • EVR $24.72
  • Revenue Next Year
  • RDY $2.61
  • EVR $17.06
  • P/E Ratio
  • RDY $17.14
  • EVR $24.42
  • Revenue Growth
  • RDY 14.10
  • EVR 27.05
  • 52 Week Low
  • RDY $12.26
  • EVR $148.63
  • 52 Week High
  • RDY $16.17
  • EVR $364.42
  • Technical
  • Relative Strength Index (RSI)
  • RDY 36.71
  • EVR 44.49
  • Support Level
  • RDY $13.37
  • EVR $311.88
  • Resistance Level
  • RDY $13.52
  • EVR $309.18
  • Average True Range (ATR)
  • RDY 0.25
  • EVR 10.64
  • MACD
  • RDY -0.09
  • EVR -0.51
  • Stochastic Oscillator
  • RDY 15.21
  • EVR 38.82

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About EVR Evercore Inc.

Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.

Share on Social Networks: